Dean M. Harvey

Promoting Fair Competition

Located in our San Francisco office, Dean M. Harvey represents individuals and companies in antitrust, business tort, employment, and intellectual property litigation.

Dean’s cases remedy and prevent wrongful conduct by dominant firms. These precedent-setting lawsuits concern a wide variety of industries and markets. Remedies include reimbursing purchasers who have overpaid for price-fixed products; preventing monopolists from stifling innovation and eliminating competition; and obtaining damages for businesses, inventors, and copyright owners.

For instance, Dean was a leader in the class action against Google, Apple, Intel and other tech giants for allegedly conspiring to suppress the mobility and compensation of their technical employees. This landmark case resulted in the largest recovery (by far) of any class action asserting antitrust claims in the employment context: $435 million. The Daily Journal described the case as the “most significant antitrust employment case in recent history,” adding that it “has been widely recognized as a legal and public policy breakthrough.”

Dean continues the fight to ensure that employees receive competitive compensation. He currently represents a doctor in a class action alleging an unlawful no-hire agreement between the medical schools of Duke University and the University of North Carolina.

Dean represented consumers in the firm’s litigation against generic drug makers for blocking access to affordable, generic versions of the brand name prescription drug Cipro. The California Supreme Court granted review, and on May 7, 2015, issued a landmark decision upholding the rights of consumers to challenge anticompetitive deals between brand name prescription drug makers and generic drug makers. On April 21, 2017, the trial court granted final approval to the last settlement, bringing total settlements achieved in the case to $399 million, nearly $68 million more than plaintiffs’ damages estimate. The trial court described the outcome as “extraordinary,” adding that it was “not aware of any case” that “has taken roughly 17 years,” where, net of fees, end-payor “claimants will get basically 100 cents on the dollar[.]”

Dean also represents individual employees, businesses, and intellectual property owners. For example, Dean represents the photographer who created the original image upon which Nike allegedly based its Michael Jordan “Jumpman” logo. The copyright case seeks to ensure that artists receive protection for their creative expression.

Prior to joining Lieff Cabraser, Dean represented both plaintiffs and defendants in antitrust class actions and other complex commercial cases. He previously worked for the Antitrust Division of the United States Department of Justice, and was a Law Clerk to the Honorable James V. Selna of the United States District Court for the Central District of California.

In 2017, the American Bar Association recognized Dean as one of the top 40 young lawyers in the country, and the Daily Journal included Dean in its “Top 40 Under 40” list of the most esteemed California attorneys under the age of 40. In 2016, Dean received a California Lawyer Attorneys of the Year (CLAY) award for the Cipro antitrust litigation. In 2015, Dean was a finalist for the American Antitrust Institute’s annual award for “Outstanding Antitrust Litigation Achievement By A Young Lawyer.” From 2013 to the present, Super Lawyers has named Dean a “Super Lawyer,” after naming him a “Rising Star” from 2010 through 2012. In 2013, The Recorder recognized Dean as a “Lawyer on the Fast Track,” one of 50 attorneys in California “whose early accomplishments indicate they will be tomorrow’s top lawyers and leaders.” In 2006, Dean received the first annual William E. Swope Antitrust Writing Award for his paper, “Anticompetitive Social Norms as Antitrust Violations,” published by the California Law Review.

Dean is Co-Chair of the American Bar Association Section of Antitrust Law, Competition Torts Committee, and has served as a member of the Law360 Competition Editorial Advisory Board.